In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination (Q30250977)
Jump to navigation
Jump to search
scientific article (publication date: May 2017)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination |
scientific article (publication date: May 2017) |
Statements
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination (English)
0 references
May 2017
0 references
11
0 references
5
0 references
e0005584
0 references
8 May 2017
1 reference
1 reference
1 reference